We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An artificial intelligence (AI) algorithm developed at the Mayo Clinic in Rochester, Minn., used data from the Apple Watch to identify patients with a weak heart pump, providing results similar to that of a medical treadmill test, according to the researchers. Read More
Abbott reported that almost nine out of 10 patients treated with its TactiCath sensor-enabled (SE) ablation catheter for persistent atrial fibrillation (AFib) in a clinical study remained symptom-free up to 15 months later. Read More
A retrospective study of GeneDx’s genetic test for autism spectrum disorder (ASD) showed higher diagnostic rates and shorter diagnosis wait times than traditional genetic testing methods, according to the company. It also identified genes that were not previously linked to autism. Read More
Bioretec’s bioresorbable implant for pediatric wrist fractures had a significantly lower complication rate than traditional metallic Kirschner-wires (k-wires) and did not require a second surgery, according to research conducted at medical facilities in Hungary. Read More
An artificial intelligence (AI)-enabled image analysis technology from PreciseDx has successfully diagnosed Parkinson’s disease in living patients prior to the onset of severe symptoms. Read More
Patients with tricuspid regurgitation showed significant improvements in heart-blood flow one year after receiving Edward Lifesciences’ investigational Pascal transcatheter tricuspid-valve repair system, researchers reported. Read More
Inivata released data at the American Association for Cancer Research Annual Meeting this week demonstrating the potential of its RaDaR assay for the detection of minimal residual disease (MRD) in cancer and its recurrence. Read More
Natera’s Prospera lung donor-derived DNA test has shown positive results in a study assessing rejection and lung-function injury in transplant patients. Read More
Synchron’s Stentrode investigational brain-computer interface device has been found safe and effective in a small study of patients with paralysis caused by amyotrophic lateral sclerosis (ALS). Read More
Roche and Bristol Myers Squibb (BMS) are teaming up to use artificial intelligence (AI) to support the use of two assays in clinical trials for tumor treatment. Read More
ResApp Health has touted positive study results showing its smartphone, audio-based COVID-19 screening test correctly detected the coronavirus in 92 percent of infected people. Read More